A Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Vaccinations of Ad26.RSV.preF One Year Apart in Adults Aged 60 Years and Older in Stable Health
Clinical trial NCT02926430 · COMPLETED
Trial details
- NCT number
- NCT02926430
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-08
- Primary completion
- 2018-03-14
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.